Endothelial TBK1 is a novel target of EndMT and atherosclerosis

Yujie Pu; Li Wang; Yu Huang

doi:10.1111/bph.16105

Endothelial TBK1 is a novel target of EndMT and atherosclerosis

Yujie Pu
, Li Wang
, Yu Huang

Department of Biomedical Sciences

Research output: Chapters, Conference Papers, Creative and Literary Works › RGC 32 - Refereed conference paper (with host publication) › peer-review

Original language	English
Title of host publication	Abstracts of the 19th World Congress of Basic & Clinical Pharmacology 2023
Pages	121-122
DOIs	https://doi.org/10.1111/bph.16105
Publication status	Published - Jul 2023
Event	19th World Congress of Basic and Clinical Pharmacology - Glasgow, United Kingdom Duration: 2 Jul 2023 → 7 Jul 2023

Publication series

Name	British Journal of Pharmacology
Number	Supplement 1
Volume	180
ISSN (Print)	0007-1188
ISSN (Electronic)	1476-5381

Conference

Conference	19th World Congress of Basic and Clinical Pharmacology
Place	United Kingdom
City	Glasgow
Period	2/07/23 → 7/07/23

Bibliographical note

Full text of this publication does not contain sufficient affiliation information. With consent from the author(s) concerned, the Research Unit(s) information for this record is based on the existing academic department affiliation of the author(s).

Funding

This study is supported by HMRF 07181286 and SRFS2021-4S04.

RGC Funding Information

RGC-funded

Access Output

10.1111/bph.16105

Other Access Options

Check CityUHK Library

Permanent Link

Right click to copy link

Cite this

@inproceedings{3d392fa7de6b4edc829d930d58ff4dbe,

title = "Endothelial TBK1 is a novel target of EndMT and atherosclerosis",

author = "Yujie Pu and Li Wang and Yu Huang",

note = "Full text of this publication does not contain sufficient affiliation information. With consent from the author(s) concerned, the Research Unit(s) information for this record is based on the existing academic department affiliation of the author(s).; 19th World Congress of Basic and Clinical Pharmacology ; Conference date: 02-07-2023 Through 07-07-2023",

year = "2023",

month = jul,

doi = "10.1111/bph.16105",

language = "English",

series = "British Journal of Pharmacology",

number = "Supplement 1",

pages = "121--122",

booktitle = "Abstracts of the 19th World Congress of Basic \& Clinical Pharmacology 2023",

}

Pu, Y, Wang, L & Huang, Y 2023, Endothelial TBK1 is a novel target of EndMT and atherosclerosis. in Abstracts of the 19th World Congress of Basic & Clinical Pharmacology 2023. British Journal of Pharmacology, no. Supplement 1, vol. 180, pp. 121-122, 19th World Congress of Basic and Clinical Pharmacology, Glasgow, United Kingdom, 2/07/23. https://doi.org/10.1111/bph.16105

Endothelial TBK1 is a novel target of EndMT and atherosclerosis. / Pu, Yujie; Wang, Li ; Huang, Yu.
Abstracts of the 19th World Congress of Basic & Clinical Pharmacology 2023. 2023. p. 121-122 (British Journal of Pharmacology; Vol. 180, No. Supplement 1).

Research output: Chapters, Conference Papers, Creative and Literary Works › RGC 32 - Refereed conference paper (with host publication) › peer-review

TY - GEN

T1 - Endothelial TBK1 is a novel target of EndMT and atherosclerosis

AU - Pu, Yujie

AU - Wang, Li

AU - Huang, Yu

N1 - Full text of this publication does not contain sufficient affiliation information. With consent from the author(s) concerned, the Research Unit(s) information for this record is based on the existing academic department affiliation of the author(s).

PY - 2023/7

Y1 - 2023/7

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001043027400090

U2 - 10.1111/bph.16105

DO - 10.1111/bph.16105

M3 - RGC 32 - Refereed conference paper (with host publication)

T3 - British Journal of Pharmacology

SP - 121

EP - 122

BT - Abstracts of the 19th World Congress of Basic & Clinical Pharmacology 2023

T2 - 19th World Congress of Basic and Clinical Pharmacology

Y2 - 2 July 2023 through 7 July 2023

ER -

Endothelial TBK1 is a novel target of EndMT and atherosclerosis

Publication series

Conference

Bibliographical note

Funding

RGC Funding Information

Access Output

Other Access Options

Permanent Link

Other Files and Links

SRFS: Systemic Benefits of Physical Activity: Crosstalk between Organs on Signal Transduction from Mechano-stimulation to Metabolism

HMRF: Selective PPARα Activation Directly Protects Vascular Function through Inhibition of YAP/TAZ-Mediated Oxidative Stress and Inflammation

Cite this

Endothelial TBK1 is a novel target of EndMT and atherosclerosis

Publication series

Conference

Bibliographical note

Funding

RGC Funding Information

Access Output

Other Access Options

Permanent Link

Other Files and Links

Projects

SRFS: Systemic Benefits of Physical Activity: Crosstalk between Organs on Signal Transduction from Mechano-stimulation to Metabolism

HMRF: Selective PPARα Activation Directly Protects Vascular Function through Inhibition of YAP/TAZ-Mediated Oxidative Stress and Inflammation

Cite this